A Phase I Clinical Study of High-Dose Ketoconazole Plus Weekly Docetaxel in Metastatic Castration-Resistant Prostate Cancer

PURPOSE: High-dose ketoconazole and docetaxel have shown activity as single agents against castration-resistant prostate cancer (CRPC). The goal of this phase I study was to determine the maximum tolerated doses, side effects, and pharmacokinetic interaction of coadministered docetaxel and ketoconaz...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Figg, William D., Woo, Sukyung, Zhu, Wenhui, Chen, Xiaohong, Ajiboye, Atinuke, Steinberg, Seth M., Price, Douglas K., Wright, John J., Parnes, Howard L., Arlen, Philip M., Gulley, James L., Dahut, William L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2010
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3474294/
https://ncbi.nlm.nih.gov/pubmed/20399458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.02.020
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items